Stock Analysis · Bulls vs Bears

IperionX IPX

🐂 Bulls vs Bears 🐻Report #210 Oct 2026
★ Willem owns this stock · 4.4% of the portfolioOlder version — see the latest →
74
high risk▼ −6 vs last
🐂 6vs8 🐻
Bears lead
27%
▲ Chance of the biggest tailwind the forecasts miss
62%
▼ Chance of the biggest headwind the forecasts miss
The verdict

IperionX is a government-sponsored bet that a lab-born titanium process can become a low-cost industrial supply chain. The geopolitical need is real, but 18 months after "full commissioning" the plant still runs at a small fraction of nameplate and sells almost nothing. This dive is materially more sceptical on execution than 1. The price has fallen ~24% since then, so less success is now priced in. The next two…

🎙️ Bulls vs Bears podcast — IperionX
Alex and Sam debate every bull and bear argument · 14:49
0:0014:49
⤓ Download

Written by Claude (Anthropic’s AI) from public sources · Willem owns IPX · AI can make mistakes — numbers in brackets point to the sources · Not financial advice

🐂 Bull arguments 6

  1. 1The US government is underwriting the build-outStrong
  2. 2A genuine strategic supply gapStrong
  3. 3Potentially disruptive unit costsMedium
  4. 4Value lives in finished parts, and the parts test wellMedium
  5. 5Titan: a second, mineral-and-rare-earth assetMedium
  6. 6Insiders are buying on the open market, and nobody is sellingMedium

🐻 Bear arguments 8

  1. 1The production ramp is far behind promisesHigh
  2. 2Funding gap and repeated dilutionHigh
  3. 3No proof yet that customers will buy volume at a profitable priceHigh
  4. 4Credibility, controls and short-seller pressureMedium
  5. 5One funder, one site, specialised suppliersMedium
  6. 6Better-funded rivals and cheap imports set the priceMedium
  7. 7Titan's study looks optimistic and the project is far offMedium
  8. 8Redomiciliation to Texas adds near-term frictionLow

Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).

Bull case — all positive points (most important first)

🐂 Bull #1The US government is underwriting the build-out

  • The point: Washington is effectively the venture investor. It is paying for most of the equipment, giving free feedstock and handing out task orders, which lowers the equity needed and signals strategic priority.
  • Evidence:
    • DPA Title III US$12.7M is fully reimbursed. IBAS US$47.1M is fully obligated, with US$34.7M remaining. Together that is US$37.1M of obligated reimbursable funding left at 30 June 2026 [1,2].
    • The SBIR IDIQ has a US$99M ceiling with US$79.2M still open after Task Order 2 [9].
    • About 290 t of government scrap was transferred at no cost [1].
  • Why it matters: each dollar of reimbursed capex is a dollar not raised at today's depressed share price. A sole-source-style IDIQ also lets the Army place further orders quickly, without a new competition.
  • 😈 Devil's advocate:
    • The money mostly buys machines the government keeps title to, not products.
    • IBAS requires a US$49.2M company match, so it creates equity needs as well as easing them [1].
    • Task Order 1 had produced no cash received by 30 June [2].
    • IDIQ ceilings are not commitments.
    • Defence appropriations are on a continuing resolution to 2026-12-04, and ~93% of the requested munitions increase depends on a reconciliation bill whose military portion was cut to US$60B in the House [39].
  • Verdict: Strong as a survival and validation point; weak as a revenue point. It lowers the odds of failure but doesn't prove a business.

🐂 Bull #2A genuine strategic supply gap

  • The point: the US is fully import-dependent for titanium sponge at a time of defence rearmament, and incumbents are capacity-constrained. A domestic route has a structural customer.
  • Evidence:
    • US sponge production: none since the last Utah plant closed in 2024. Net import reliance is 100%; record imports of ~44,000 t in 2025, ~73–77% from Japan [25].
    • China produced 260,000 t of the world's ~370,000 t sponge in 2025 (70%) [25].
    • Airbus still sources some Russian VSMPO titanium (April 2026) [40].
    • ATI says lead times on some premium titanium are close to two years [30].
    • Toho Titanium projects an ex-China sponge deficit from 2028 (via Argus, secondary [25]).
    • DFARS rules require US-melted specialty metals including titanium for many weapons.
  • Why it matters: defence buyers may pay a security premium for domestic, short-lead-time parts, which is exactly IperionX's segment.
  • 😈 Devil's advocate:
    • The "gap" is filled today by Japan, an ally. Imported sponge is ~US$12/kg [25], and Osaka Titanium is adding 10,000 t/yr by FY2027 [28].
    • Washington declined sponge duties in 2019–20 precisely because Japan is a reliable supplier [41].
    • IperionX's whole 2027 target (1,400 tpa) is under 2% of Japan's output.
    • Need is not the same as willingness to pay a premium.
  • Verdict: Strong The gap is documented by USGS and policy treats titanium as critical. The open question is who captures it, not whether it exists.

🐂 Bull #3Potentially disruptive unit costs

  • The point: if HAMR plus HSPT hit their projected costs, IperionX could make parts cheaper than the forged-and-machined route, not merely "domestic at a premium".
  • Evidence:
    • Projected steady-state powder cost is ~US$55/kg at full use of 200 tpa (20-F) [1], and ~US$29/kg operating cost at 1,400 tpa (company, September 2025) [6].
    • Conversion costs are projected at US$4–30/kg for pressing routes versus US$100–375/kg for laser 3D printing [6].
    • GenX continuous runs: >500 kg in 41 hours, 6× batch throughput, >75% less power, >45% less magnesium, >60% less hydrogen [10]. Oxygen met Grade 5 in 7 of 8 angular samples and Grade 23 in all spherical samples [10].
    • Jefferies (initiated 2026-09-02, Buy, US$26) reportedly credits ~90% lower energy, 70–80% lower capex and ~50% lower opex versus incumbents (paraphrased secondary summary [22]).
  • Why it matters: cost leadership would make the business durable without subsidies and open non-defence markets (automotive, electronics).
  • 😈 Devil's advocate:
    • Every figure is a projection. No realised cost per kg has ever been disclosed.
    • A plant running at ~15% of nameplate has very high unit costs.
    • A 2021 academic paper cited by Spruce Point calls HAMR "not energy-efficient" at 700–800 °C [16].
    • GenX is a pilot result with internally inconsistent sample counts [10], and the company says it is "not required" for the 200 tpa ramp.
    • Boeing and Arconic, early partners, did not commercialise the IP (Spruce Point allegation [16]).
  • Verdict: Medium GenX is real new evidence of process progress, but the bull rests on projections until a quarter shows cost per kg at volume.

🐂 Bull #4Value lives in finished parts, and the parts test well

  • The point: by selling near-net-shape parts instead of commodity powder, IperionX can earn component pricing (company target US$180–400/kg [6]) and save customers lead time and waste.
  • Evidence:
    • Army DEVCOM and independent testing found fasteners with yield torque up to ~20% above SAE Grade 8 steel and tensile strength ~15% above standard aerospace titanium fastener benchmarks [1].
    • Carver Pump impellers were made in under a week, against casting lead times of 12+ months [4].
    • Rheinmetall targets a 40–45% weight cut versus steel parts [1].
    • Task Order 2 is building in-house fastener finishing [9].
  • Why it matters: fasteners and pins are high-volume, repeat-order items. Once qualified on a vehicle such as the JLTV (Joint Light Tactical Vehicle), they can reorder for years.
  • 😈 Devil's advocate:
    • Test performance on a few hundred parts is not production qualification.
    • The company's own table puts aerospace entry at 2028 [3].
    • The HSPT sintering furnace is the bottleneck, and larger furnaces were arriving late [2].
    • Titanium fasteners compete with cheap steel parts. Price per part, not strength, usually decides.
  • Verdict: Medium This is the most concrete commercial wedge, and the defence vehicle programmes are the likeliest first repeat revenue.

🐂 Bull #5Titan: a second, mineral-and-rare-earth asset

  • The point: Titan gives a domestic titanium-mineral feedstock plus zircon and heavy rare earths (dysprosium, terbium), which the US cannot source outside China.
  • Evidence:
    • DFS NPV8 US$813M, IRR 39.4%, payback 3.6 years; reserve 117 Mt at 3.2% heavy minerals [7].
    • Key mining and NPDES (water discharge) permits were issued in 2023 [7].
    • US heavy-rare-earth import reliance is 100%, and no US company produces at sustained commercial scale [27].
    • Ex-China prices carry a big premium:
      • Platts: North American delivered terbium oxide ~US$4,900/kg and dysprosium oxide ~US$1,200/kg (2026-03-31) [34].
      • SMM: Chinese domestic dysprosium metal ~US$239/kg (2026-09-03) [36].
    • Jefferies reportedly values Titan at ~US$15 per ADS on its own (secondary [22]).
  • Why it matters: if Titan were funded by government and partners, it could be worth a large share of today's ~US$0.6B market value.
  • 😈 Devil's advocate:
    • The DFS assumes rutile at US$1,471/t, against US$1,140/t (USGS 2025) and Iluka's realised US$1,256/t in Q2 2026 [7,26,29].
    • It assumes 100% equity funding [7]. There is no offtake and no financing.
    • The processing plants still need permits, and the mining permit runs only to ~August 2028 [7].
    • The heavy-rare-earth premium depends on Chinese policy. Export-control escalation was suspended for a year in November 2025 and could be relaxed further [27].
    • Most of Titan's tonnage goes into paint pigment, a housing-cycle market [26].
  • Verdict: Medium weak. It is a real option, but until financing exists the market reasonably discounts it heavily.

🐂 Bull #6Insiders are buying on the open market, and nobody is selling

  • The point: directors put meaningful personal money in at lower prices.
  • Evidence:
    • On-market purchases (SEC Form 4):
      • March 2026 by Arima, Hannigan, Symonds and Tripeny.
      • April 2026 by Arima, Hannigan, Symonds and Martin.
      • July 2026, right after the offering, by Arima, Hannigan, Symonds, Martin and Tripeny.
    • The company totals about US$4.3M (March–April) and ~US$1.9M (July) [2,14].
    • No insider sales were found since Form 4 reporting began in March 2026 [14].
    • Insiders own 15.6%, including Hannigan 7.8% and Arima 3.7% [1].
  • Why it matters: it signals that the people closest to the furnace data believe in the ramp.
  • 😈 Devil's advocate:
    • The July buys were at A$3.58/share, about US$23.5/ADS. The stock is now ~30% lower, so insider conviction hasn't protected anyone.
    • Spruce Point alleged the CEO's shares are margin-pledged (unverified [16]), which would make buying partly defensive.
    • 17.8% of votes opposed the CEO and chair performance rights in March [13].
  • Verdict: Medium It is genuine open-market buying, but a weak predictor when the outcome hinges on engineering.

Bear case — all negative points (most important first)

🐻 Bear #1The production ramp is far behind promises

  • The point: a year after "full commissioning", output is a small fraction of nameplate, and dated milestones keep slipping.
  • Evidence:

    • Monthly output, read from the bar chart in the June 2026 report (approximate) [2]:

      Month Output (t)
      Oct–Dec 2025 (monthly average) ~0.8
      January 2026 ~1.3
      February ~2.6
      March 4.2
      April ~0.9
      May ~1.8
      June ~2.4
      July (forecast) ~3.5

    • The June quarter was ~5.1 t against ~8.1 t in March.

    • The 200 tpa target equals 16.7 t/month, roughly 7× the June rate, to be reached by December [2].

    • The cause was furnace downtime. The furnace, the fault and the OEM are not named [2].

    • History: first metal slipped from mid-2024 to August 2024. "Steady state by mid-2025" became ~0.8 t/month in late 2025. The "EBITDA-positive by end-2026" target is no longer repeated [1,5,6].

  • Why it matters: unit cost, customer confidence and qualification all depend on reliable volume. Every quarter of delay burns ~US$12–16M of cash [1].
  • 🛡️ Counter-argument:
    • March output was mostly lower-yield spherical powder, and angular output would be higher like for like [3].
    • The furnace fault was fixed with the OEM, and downtime "did not affect" downstream powder availability [2].
    • Nameplate rose from 125 to 200 tpa without capex [1].
  • Severity: High Even generously, the company must lift output about seven-fold in six months, with a track record of slippage.

🐻 Bear #2Funding gap and repeated dilution

  • The point: the company needs far more money than it has, and equity has been the main source, often raised after price falls.
  • Evidence:
    • FY26 net loss US$66.8M (FY25 US$35.3M). Operating cash flow −US$45.0M, investing −US$18.6M [1].
    • Cash US$35.2M at 30 June; pro forma ~US$84M after the US$50M July offering at US$21.98 [2,8].
    • Consensus FY27 free cash flow is about −US$73M (S&P via stockanalysis, thin coverage [19]).
    • Commitments ahead: a US$49.2M company match for IBAS, the 1,400 tpa build (expansion capex US$75.1M [6]), and Titan's US$228.1M Phase 1 modelled on 100% equity [1,7].
    • More than US$250M has been raised since listing [1]. Spruce Point said the July raise "undercut investors" near a 52-week low [18].
  • Why it matters: at ~US$16.5/ADS, raising US$100M would mean issuing roughly 17% more shares (my arithmetic: 6.1M ADS on 36.2M).
  • 🛡️ Counter-argument:
    • US$37.1M of obligated government reimbursements is still to come [1].
    • Titan could be funded by DoW, EXIM or Office of Strategic Capital (OSC) loans; precedents include MP Materials (US$150M) and Energy Fuels (US$725M conditional) [27,37].
    • The 20-F has no going-concern doubt for 12 months [1].
  • Severity: High Runway is roughly 12–18 months at current burn, and the company cannot fund both growth projects without new capital.

🐻 Bear #3No proof yet that customers will buy volume at a profitable price

  • The point: after years of programmes, there is no recognised revenue, no realised price, and no binding volume contract.
  • Evidence:
    • Revenue is zero, and FY26 receipts were about US$63k [1].
    • Orders are prototypes: Carver ~US$100k, Rheinmetall US$0.3M, Ford ~US$49k (2023) [1,43].
    • United Stars is a framework cancellable on 60 days' notice [44].
    • Indicative pricing is only "indicative": US$50–1,000+/kg depending on segment [3].
    • Spruce Point says active customer engagements fell from ~100 to 22 (allegation [16]).
    • Consensus nonetheless expects FY27 revenue of ~US$7.9M and FY28 revenue of ~US$103M (one-analyst-level coverage [19]).
  • Why it matters: without converted orders, extra capacity simply raises burn. The FY28 consensus implies a step-change no contract yet supports.
  • 🛡️ Counter-argument:
    • Defence qualification typically precedes volume by 12+ months, and fastener and pin programmes with the Army and Rheinmetall are moving through test stages.
    • Task Order 2 includes in-house finishing that is needed before volume supply [9].
  • Severity: High It is the central unknown, and the evidence today is thin.

🐻 Bear #4Credibility, controls and short-seller pressure

  • The point: the stock carries a confidence discount from accounting slips and an active short seller.
  • Evidence:
    • The H1 FY26 report (2026-03-12) was followed by a correction of what the company called a "typographical error". Plaintiff firms said it overstated a right-of-use asset by about US$330M; that magnitude is UNCONFIRMED and was seen only in solicitations [17].
    • The ADS fell from US$49.61 on 2026-03-11 to US$24.70 on 2026-03-25 [21]. The ASX issued a price query, and the company answered on grant accounting [12].
    • The 20-F discloses past material weaknesses in internal control. FY26 controls were assessed effective [1].
    • Spruce Point's "Strong Sell" (October 2025) claimed 70–95% downside. The company's rebuttal did not answer point by point [15,16].
    • ASX short positions were above 9% of the register in July 2026 (Capital Brief only [18,42]). Nasdaq short interest rose to 3.4% of float on 2026-09-30 [20].
    • A law-firm "investigation" was announced 2026-08-17. No class action filing was found [19].
  • Why it matters: high short interest and doubts about disclosure make equity raises more expensive and amplify bad quarters.
  • 🛡️ Counter-argument: the correction was presentational; net loss and cash were unaffected as far as found. FY26 controls were signed off as effective [1]. Insiders kept buying [14].
  • Severity: Medium

🐻 Bear #5One funder, one site, specialised suppliers

  • The point: nearly all non-equity money comes from US defence budgets, all production is in one Virginia campus, and key furnaces come from few suppliers.
  • Evidence:
    • Government programmes total US$59.8M plus the IDIQ [1].
    • Title to federally funded equipment vests with the US government, and its transfer back is optional [1].
    • Reimbursement lags: about US$6.6M was paid but not yet reimbursed at December 2025 [12].
    • The June outage depended on the furnace OEM [2].
    • FY27 defence appropriations are unresolved, with a continuing resolution to 2026-12-04 [39].
  • Why it matters: a budget delay, a change in DoW priorities or one long furnace outage hits cash and output directly.
  • 🛡️ Counter-argument: titanium supply chains have bipartisan support, and DoW keeps adding awards: Task Order 2 in August 2026 and OSW-S up to US$6.6M in July 2026 [9].
  • Severity: Medium

🐻 Bear #6Better-funded rivals and cheap imports set the price

  • The point: IperionX competes with very cheap imported sponge and with other subsidised domestic powder makers.
  • Evidence:
    • Imported sponge is US$12/kg (2025) [25], and Chinese grade-0 sponge was RMB 45–46k/t (US$6/kg) in July 2026 [48].
    • Osaka Titanium is adding 10,000 t/yr [28].
    • 6K Additive is scaling scrap-based powder to >1,000 tpa with DPA and EXIM money [31].
    • Tekna is winning US defence powder orders [46].
    • Spruce Point claims industry powder capacity is 3.5× shipments [16].
  • Why it matters: the projected US$55/kg powder cost is far above sponge (a different product), and powder alone is at risk of commoditisation. Only parts earn a premium.
  • 🛡️ Counter-argument: sponge is not a part; buy-to-fly waste and 2-year lead times make the delivered cost of a finished titanium part far higher than US$12/kg. IperionX's pitch is cost per finished part [1,30].
  • Severity: Medium

🐻 Bear #7Titan's study looks optimistic and the project is far off

  • The point: the US$813M NPV leans on rich prices and assumes funding that doesn't exist.
  • Evidence:
    • Rutile is assumed at US$1,471/t versus US$1,140–1,256/t in the market [7,26,29].
    • No offtake, 100% equity assumption, and further permits needed [7].
    • Commissioning is June 2028 at the earliest.
    • The integrated Atlas+Titan study is not due until end-2026 [2].
  • Why it matters: if investors give Titan credit (Jefferies ~US$15/ADS [22]), a weaker restudy or financing failure would remove a large part of the valuation support.
  • 🛡️ Counter-argument: heavy-rare-earth prices outside China have risen far above DFS-era levels [34], which could offset softer rutile. Atlas could cut capex [7].
  • Severity: Medium low for the business; medium for the share price.

🐻 Bear #8Redomiciliation to Texas adds near-term friction

  • The point: a court-approved scheme would move the parent to Texas and end foreign-private-issuer status (10-K/10-Q reporting).
  • Evidence: it needs approval by 75% of votes cast. The company flags tax, shareholder-rights and litigation-environment risks. No timeline is set [1,11].
  • Why it matters: costs and distraction, and more US securities-litigation exposure. It could also bring US index eligibility (Interpretation).
  • 🛡️ Counter-argument: it simplifies the capital structure (no ADS) and may widen the US investor base.
  • Severity: Low

Tailwinds NOT in the forecasts

  • US government financing for Titan and/or the 1,400 tpa build — 27% chance within 36 months · Impact if it happens: High
    • What it is: a DoW, OSC, EXIM or DOE loan or equity package, like MP Materials (US$400M preferred plus US$150M loan) or Energy Fuels (US$725M conditional OSC loan) [27,37].
    • Why it's not priced in: the DFS assumes 100% equity [7]. The company says only that it is "engaged with the U.S. Government regarding potential funding pathways". Consensus models a deeply negative FY27 FCF [19].
    • What would trigger it / the sign to watch: an OSC or EXIM letter of interest, inclusion of titanium or HREE in a DoW critical-minerals award. The OSC National Security Fund Finance application window closes 2026-11-01 [38].
    • Why this probability: precedents exist and titanium is a named critical mineral. But IperionX's EXIM history is small (~US$11M), and Titan has no offtake to secure a loan against.
  • A volume-defence "anchor" order converting the Army/Rheinmetall prototypes into serial production — 33% chance · Impact: Medium
    • What it is: a production order (≥US$10M/yr of parts) for JLTV fasteners, track pins or Rheinmetall vehicle components.
    • Why it's not priced in: the current orders are equipment-funding and prototypes. The FY28 consensus of ~US$103M revenue implies something like this but rests on one or two models, and the stock price shows the market does not believe it [19].
    • What would trigger it / the sign to watch: a funded Task Order 3 for parts (not equipment), or Rheinmetall serial pricing.
    • Why this probability: fastener test data are good and the Army is clearly engaged, but defence qualification cycles have usually exceeded the company's timelines.
  • Titanium-specific trade protection or procurement mandate — 13% chance · Impact: High
    • What it is: minimum import prices or tariffs on titanium sponge or mill products under the Section 232 critical-minerals action (Proclamation 11001, 2026-01-14), or a tighter DFARS domestic-source rule [32,33].
    • Why it's not priced in: the proclamation chose negotiation, not tariffs. No outcome after the July 2026 deadline was found. The 2019–20 sponge case ended without duties [41].
    • What would trigger it / the sign to watch: Commerce or USTR announcing minimum import prices for processed critical minerals; FY27 NDAA titanium language.
    • Why this probability: the tool is live (it was used for polysilicon in August 2026 [49]), but Japan, the main supplier, is an ally with a trade deal.
  • Ex-China heavy-rare-earth premium makes Titan's concentrate strategically valuable — 20% chance · Impact: Medium
    • What it is: a binding offtake or prepayment for Titan's heavy rare-earth concentrate (HREC) from a Western separator or magnet maker at prices well above the DFS assumption.
    • Why it's not priced in: no HREC offtake exists [7]. Analysts mostly value Titan on the DFS.
    • What would trigger it / the sign to watch: an MOU with Energy Fuels, MP Materials, Iluka or another separator; North American dysprosium and terbium assessments staying near Platts' March 2026 levels [34].
    • Why this probability: the premium is real today, but the feed is years away and buyers prefer near-term supply.

Headwinds NOT in the forecasts

  • Another equity raise of ≥15% of the share count below US$20/ADS — 62% chance within 12 months · Impact if it happens: High
    • What it is: an underwritten offering, at-the-market selling or placement to fund the IBAS match, the 1,400 tpa build or Titan early works.
    • Why it's not priced in: sell-side targets (average ~US$42 [20]) and EPS forecasts do not show a rising share count. Consensus FY27 FCF of −US$73M against US$84M pro-forma cash forces the issue [19].
    • What would trigger it / the sign to watch: quarter-end cash below US$55M, a new F-3/424B5 filing, or ATM language in the September-quarter report.
    • Why this probability: FY27 burn alone nearly exhausts pro-forma cash, the company has raised roughly every 6–12 months, and a government-funding substitute within 12 months is less likely than not.
  • The 200 tpa run-rate is clearly missed at end-2026 — 58% chance · Impact: Medium
    • What it is: December 2026 monthly output below ~10 t (120 tpa annualised), and/or the target re-dated.
    • Why it's not priced in: management still says "on track" [2]. The price has fallen, but analysts' FY27 revenue assumes the ramp.
    • What would trigger it / the sign to watch: September-quarter output (report due ~2026-10-27 [19]) below ~15 t for the quarter.
    • Why this probability: a seven-fold rise in six months with one sintering bottleneck and a history of slippage is more likely missed than hit. GenX and new furnaces give it a real chance.
  • Securities class action or renewed short report — 28% chance · Impact: Low-Medium
    • What it is: a filed lawsuit over the March correction or the July raise, or a second Spruce Point report (hinted in March 2026 [17]).
    • Why it's not priced in: only investigations have been announced so far.
    • What would trigger it / the sign to watch: a filed complaint, or a new short-seller publication around the redomiciliation vote.
    • Why this probability: plaintiff firms are active and Spruce Point publicly flagged a follow-up, but there is no hard evidence of misstatement beyond the corrected figure.
  • China extends or loosens its rare-earth export-control suspension, cutting the ex-China premium — 40% chance · Impact: Low (for today's business), Medium (for Titan's value)
    • What it is: the one-year suspension of China's October 2025 controls, from November 2025, may be extended or loosened (single-source expiry date ~2026-11-10 [35]).
    • Why it's not priced in: Titan bulls lean on current ex-China dysprosium and terbium premiums [22,34].
    • What would trigger it / the sign to watch: US-China trade-truce headlines in November 2026, and Chinese general export licences [27].
    • Why this probability: both sides have tended to extend truces, but the US entity-specific listing of June 2026 shows control is still being used [27].

Investment Risk Score: 74/100

Risk area Weight Score (0–100) Why
Business & competition 25% 75 Unproven process economics, no revenue, cheap imported sponge and subsidised domestic powder rivals. The edge is strategic, not yet commercial.
Financial health & dilution 20% 82 ~US$84M pro-forma cash against ~US$45M operating burn plus a US$49M IBAS match. Titan's US$228M is unfunded, and there is a history of raises at lows.
Execution (delivering the plan) 20% 82 June exit rate ~29 tpa against a 200 tpa December target, a single sintering bottleneck, and repeated milestone slippage.
Dependency & concentration 15% 78 Almost all non-equity money is from US defence, equipment title is held by the government, there is one site, and furnace OEMs are critical.
Regulation, policy & geopolitics 10% 50 Policy is mostly a tailwind, but the budget continuing resolution, the open Section 232 outcome, China rare-earth policy (Titan) and the redomiciliation cut both ways.
Sentiment & expectations 10% 55 Price has reset to US$16.48, but average targets of ~US$42 and FY28 revenue of ~US$103M still assume success. ASX shorts were >9%.

Overall = 0.25·75 + 0.20·82 + 0.20·82 + 0.15·78 + 0.10·50 + 0.10·55 = 73.75 ≈ 74 (high).

This is a pre-revenue industrial start-up whose survival depends on government money and equity markets, while its plant runs at ~15% of nameplate. The score is below deep dive #1's 80 mainly because the risk method changed: the old score treated volatility and valuation more heavily. The share-price reset also lowers expectation risk. Execution evidence got worse: the actual monthly output is now known, and the short-seller and controls history was missed last time. Like for like, overall risk is unchanged to slightly higher.

Conclusion

  • What kind of company this is: a venture-stage, government-sponsored industrial technology company with a mining option attached.
    • Owning it is a bet that (a) HAMR/HSPT can run reliably at hundreds, then thousands, of tonnes, (b) defence and industrial buyers will qualify and reorder parts at prices above that cost, and (c) Washington keeps paying for much of the build-out.
    • Titan is a separate, unfunded bet on US critical-mineral policy.
  • The 2–3 things that will decide the outcome:
    1. Monthly output trajectory to December 2026 and through 2027 (200 tpa, then 1,400 tpa).
    2. The first serial (non-prototype) parts contract with a price.
    3. Whether the next large tranche of money comes from government or from shareholders.
  • Signposts:
    • Confirm the bull case:
      1. The September-quarter report shows ≥15 t of quarterly output and a monthly exit rate ≥8 t.
      2. A funded Army Task Order 3 (or Rheinmetall serial order) for parts, not equipment.
      3. An OSC, EXIM or DoW financing letter for Titan or the 1,400 tpa build.
      4. A disclosed realised cost per kg near the US$55/kg projection.
    • Break the bull case:
      1. December 2026 exit rate below ~10 t/month, or the 200 tpa target re-dated.
      2. An equity raise below US$15/ADS without government co-funding.
      3. Another reporting correction, or a filed class action with substance.
      4. Loss of a prototype customer, or Army funding paused under the budget fight.
  • Balanced verdict:
    • The strongest bull version: the US genuinely has no domestic titanium metal production. The Pentagon is paying to build IperionX's capacity, giving it free scrap and testing its parts favourably. A continuous process (GenX) could make it a low-cost producer. Insiders keep buying, and the price has already halved from its highs.
    • The strongest bear version: after more than US$250M raised and a year of "full commissioning", the plant produced ~5 t in a quarter and the company sold ~US$63k of product. Its cost and price claims are all projections. The next growth steps cost several times its cash, and its history of slippage and a disclosure correction leave little benefit of the doubt.
    • Today the evidence leans bearish on execution and funding, and bullish on strategic relevance and government support. The September and December quarter output figures are the cleanest tests in the next four months.

Open questions & data gaps

  • Actual July–September 2026 output: not found. The September-quarter report (~2026-10-27) is the single most important missing datapoint for the execution score.
  • Realised cost per kg and realised selling prices: not found. All cost figures are company projections. This matters a lot for Bull #3.
  • The March 2026 "typographical error": its exact size and nature are not found in a company filing (the plaintiff-firm US$330M is unconfirmed). This matters moderately for the controls and credibility point.
  • Call/webinar Q&A: no transcripts are published. Management's spoken answers on Titan financing and the furnace fault could not be read.
  • Current ASX short position: only the July Capital Brief figure (>9%) was found. ASIC data was not checked.
  • Section 232 critical-minerals outcome after July 2026: not found.
  • Heavy-rare-earth prices: the sources conflict. Platts (North America delivered) and Skillings (Europe, single source) are far above Chinese domestic SMM prices. This matters for Titan only.
  • Consensus: effectively one or two models (S&P via stockanalysis). FY28–29 consensus is unreliable.
  • Jefferies rationale: seen only through a Turkish-language paraphrase. Its "US$50/kg selling price" assumption could not be reconciled with the company's ~US$55/kg cost projection.
Sources
  1. IperionX Form 20-F, fiscal year ended 30 June 2026 — SEC EDGAR — 2026-09-29 — https://www.sec.gov/Archives/edgar/data/1898601/000189860126000030/ipx-20260630.htm
  2. IperionX June 2026 Quarterly Report (6-K Ex 99.1, incl. Figure 4 output chart) — SEC EDGAR — 2026-07-30 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126030117/ef20078979_ex99-1.htm
  3. IperionX March 2026 Quarterly Report — SEC EDGAR — 2026-04-27 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126016841/ef20071580_ex99-1.htm
  4. IperionX December 2025 Quarterly Report — SEC EDGAR — 2026-01-30 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126002866/ef20064210_ex99-1.htm
  5. IperionX September 2025 Quarterly Report — SEC EDGAR — 2025-10-30 — https://www.sec.gov/Archives/edgar/data/1898601/000114036125039862/ef20057976_ex99-1.htm
  6. IperionX cost and 1,400 tpa expansion release (US$55/kg, US$29/kg) — SEC EDGAR — 2025-09-02 — https://www.sec.gov/Archives/edgar/data/0001898601/000114036125033566/ef20055002_ex99-1.htm
  7. IperionX Titan DFS release — SEC EDGAR (6-K) — 2026-06-04 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126023931/ef20075531_ex99-1.htm
  8. IperionX Announces Pricing of Public Offering / 424B5 prospectus supplement — SEC EDGAR — 2026-07-07 / 2026-07-09 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126028110/ef20077614_ex99-1.htm
  9. IperionX Secures Second U.S. Army Task Order — SEC EDGAR / IperionX — 2026-08-31 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126034918/ef20081339_ex99-1.htm
  10. IperionX Validates GenX Continuous Titanium Production — SEC EDGAR / IperionX — 2026-09-16 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126036725/ef20082093_ex99-1.htm
  11. IperionX Proposed U.S. Redomiciliation and Board Appointment — SEC EDGAR — 2026-08-03 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126030542/ef20079240_ex99-1.htm
  12. IperionX Response to ASX Price Query — SEC EDGAR — 2026-03-16 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126009611/ef20068025_ex99-1.htm
  13. IperionX Results of General Meeting — SEC EDGAR — 2026-03-19 — https://www.sec.gov/Archives/edgar/data/1898601/000114036126010403/ef20068347_ex99-1.htm
  14. IperionX insider Forms 3/4 (filing index, CIK 1898601) — SEC EDGAR — 2026-03-18 to 2026-08-12 — https://data.sec.gov/submissions/CIK0001898601.json
  15. IperionX Response to Short Seller Report — IperionX — 2025-11-17 — https://iperionx.com/2025/11/17/iperionx-response-to-short-seller-report/
  16. Spruce Point Issues "Strong Sell" on IperionX (summary of report dated 2025-10-03) — Hedge Fund Alpha — 2025-11-12 — https://hedgefundalpha.com/stocks/spruce-point-strong-sell-iperionx/
  17. Short sellers circle IperionX after typo blunder — Capital Brief — 2026-03-20 — https://www.capitalbrief.com/article/short-sellers-circle-iperionx-after-typo-blunder-as-spruce-point-hints-at-second-attack-1806f7be-b5af-475d-b035-be2d66ae74d6/
  18. Short Fuse newsletter (IperionX raise, ASX shorts >9%) — Capital Brief — 2026-07-13 — https://www.capitalbrief.com/newsletter/short-fuse-0f3ae3f5-7c9e-4894-bf0f-d8a988e21d3e/
  19. IPX stock overview and forecast (consensus, next earnings date, news) — stockanalysis.com — accessed 2026-10-10 — https://stockanalysis.com/stocks/ipx/forecast/
  20. IPX short interest and analyst ratings — MarketBeat — report date 2026-09-30 (published 2026-10-09) — https://www.marketbeat.com/stocks/NASDAQ/IPX/short-interest/
  21. IPX daily price history — Yahoo Finance chart API — accessed 2026-10-10 — https://query1.finance.yahoo.com/v8/finance/chart/IPX
  22. Jefferies initiates IperionX at Buy, US$26 target (Turkish-language summary) — Midas — 2026-09 — https://www.getmidas.com/midasin-kulaklari/jefferies-iperionx-icin-al-notu-ve-26-dolar-hedef-fiyatla-coverage-baslatti-p-730159
  23. B. Riley senkt Kursziel von 52 auf 34 Dollar — boerse-global.de — 2026-09-30 — https://www.boerse-global.de/iperionx-aktie-b-riley-senkt-kursziel-von-52-auf-34-dollar/830421
  24. IperionX Aktie: Vertrauenskrise ohne Ende — boerse-global.de — 2026-10-06 — https://www.boerse-global.de/iperionx-aktie-vertrauenskrise-ohne-ende/831247
  25. Mineral Commodity Summaries 2026: Titanium and Titanium Dioxide — USGS — 2026-02 — https://pubs.usgs.gov/periodicals/mcs2026/mcs2026-titanium.pdf
  26. Mineral Commodity Summaries 2026: Titanium Mineral Concentrates — USGS — 2026-02 — https://pubs.usgs.gov/periodicals/mcs2026/mcs2026-titanium-minerals.pdf
  27. Mineral Commodity Summaries 2026: Rare Earths (Heavy) — USGS — 2026-02 — https://pubs.usgs.gov/periodicals/mcs2026/mcs2026-rare-earths-heavy.pdf
  28. Notice Concerning Change in Investment Amount for Sponge Titanium Capacity — Osaka Titanium Technologies — 2026-03-16 — https://www.osaka-ti.co.jp/e/e_ir/pdf/e-news20260316.pdf
  29. Quarterly Review to 30 June 2026 — Iluka Resources (ASX) — 2026-07-28 — https://announcements.asx.com.au/asxpdf/20260728/pdf/0723lrry1qs81t.pdf
  30. ATI Aerospace and Defense Demand Lifts 2026 Guidance — Metalnomist — 2026-07-30 — https://www.metalnomist.com/2026/07/ati-aerospace-and-defense-demand-lifts.html
  31. 6K Additive secures $27.4M EXIM funds — Metal Powder Tech — 2026 — https://www.metal-powder.tech/?p=284474
  32. Adjusting Imports of Processed Critical Minerals and Their Derivative Products (Proclamation 11001) — The White House — 2026-01-14 — https://www.whitehouse.gov/presidential-actions/2026/01/adjusting-imports-of-processed-critical-minerals-and-their-derivative-products-into-the-united-states/
  33. Trump administration announces results of critical minerals investigation under Section 232 — Covington & Burling — 2026-01 — https://www.cov.com/news-and-insights/insights/2026/01/trump-administration-announces-results-of-critical-minerals-investigation-under-section-232-and-directs-us-officials-to-initiate-negotiations
  34. New Platts rare earth assessments reveal security-of-supply premiums in North America — S&P Global Commodity Insights — 2026-03-31 — https://www.spglobal.com/energy/en/news-research/latest-news/metals/033126-new-platts-rare-earth-assessments-reveal-security-of-supply-premiums-in-north-america (snippet only)
  35. China's Rare Earth Export Controls Drive Eightfold Price Surge in Dysprosium, Terbium — Skillings Mining Review — 2026-07-24 — https://skillings.net/chinas-rare-earth-export-controls-drive-eightfold-price-surge-in-dysprosium-terbium (single source)
  36. Dysprosium price (SMM assessment 2026-09-03) — rare-earth-mining.com — 2026-09-03 — https://rare-earth-mining.com/dysprosium-price/
  37. Energy Fuels gets $725m US loan commitment — TXF News — 2026 — https://www.txfnews.com/news/74138/Energy-Fuels-gets-725m-US-loan-commitment
  38. Office of Strategic Capital opens application window — Mintz — 2026-08-31 — https://www.mintz.com/insights-center/viewpoints/2236/2026-08-31-office-strategic-capital-opens-application-window
  39. The fight over the FY27 defense budget is on: 13 key issues — Breaking Defense — 2026-08 — https://breakingdefense.com/2026/08/the-fight-over-the-fy27-defense-budget-is-on-heres-13-key-issues-for-congress-to-resolve/
  40. Airbus still sources Russian titanium — AirInsight — 2026-04 — https://airinsight.com/?p=62749
  41. President declines to impose national security duties on imports of titanium sponge — Kelley Drye — 2020 — https://www.kelleydrye.com/viewpoints/blogs/trade-and-manufacturing-monitor/president-declines-to-impose-national-security-duties-on-imports-of-titanium-sponge
  42. "The progress here is waffle": IperionX raise reignites the shorts — Capital Brief — 2026-07 — https://www.capitalbrief.com/article/the-progress-here-is-waffle-iperionx-raise-reignites-the-shorts-fac618f6-a066-45ee-b06a-3fcaa0b0e671/ (headline/snippet only)
  43. IperionX to Produce Titanium Components for Ford Motor Company — Business Wire — 2023-06-13 — https://www.businesswire.com/news/home/20230613686758/en
  44. IperionX partners with United Stars for U.S.-sourced titanium manufacturing — Industrial Machinery Digest — 2024-04 — https://newsite.industrialmachinerydigest.com/metalworking/machining/iperionx-partners-with-united-stars-for-u-s-sourced-titanium-manufacturing
  45. IperionX analyst coverage list — IperionX — accessed 2026-10 — https://iperionx.com/investor-center/analyst-coverage/
  46. Tekna secures further titanium powder orders from US defence customer — Metal AM — 2026 — https://www.metal-am.com/tekna-secures-further-titanium-powder-orders-from-us-defence-customer/
  47. IperionX H2 2026 event summary (AI summary, not transcript) — Quartr — 2026 — https://quartr.com/events/iperionx-limited-ipx-h2-2026_Fsx6oo8u
  48. Sponge titanium prices drop 2% in July — Shanghai Metals Market — 2026-08 — https://news.metal.com/newscontent/103982297-sponge-titanium-prices-drop-2-in-july-production-up-1104-year-on-year
  49. Recent executive actions affecting critical minerals and materials — Greenberg Traurig — 2026-08 — https://www.gtlaw.com/en/insights/2026/8/recent-executive-actions-affecting-critical-minerals-and-materials
All IPX Bulls vs Bears reports
Disclaimer. AI-generated research and podcast (Claude by Anthropic, voices by Google Gemini) for educational purposes — not financial advice and not a recommendation to buy or sell. Willem (MR.INVEST) owns this stock. Check the company’s own filings before making any decision.
← All Bulls vs Bears reports